SCHEDULE: Jennison Associates Reports 11.1% Stake in Neurogene Inc.

Jennison Associates LLC has disclosed beneficial ownership of 11.1% of Neurogene Inc.'s common stock as of September 30, 2026.

Summary

• Jennison Associates LLC has filed a Schedule 13G, indicating it beneficially owns 2,229,082 shares of Neurogene Inc. common stock.
• This ownership stake represents 11.1% of the class of securities.
• The filing date is October 6, 2026, with the event date requiring the filing being September 30, 2026.
• Jennison Associates LLC is organized in Delaware and is classified as an investment adviser.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without new strategic or financial information.

Positives

• Significant institutional ownership by Jennison Associates LLC, suggesting confidence in Neurogene Inc.'s potential.
• Clear disclosure of ownership stake, providing transparency to the market.

Negatives

• The filing does not provide any new financial performance data or strategic updates for Neurogene Inc.

Risks

• As a Schedule 13G filing, it primarily reports passive ownership and does not inherently contain forward-looking risk disclosures for Neurogene Inc. itself.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from Neurogene Inc.

Industry Context

StockSavvy.ai notes that significant institutional filings like this Schedule 13G often signal growing interest from asset managers in biotechnology companies, particularly those with novel therapeutic platforms. The timing of this disclosure may reflect recent market analysis or strategic investment decisions by Jennison Associates.

Stakeholder Impact

• Shareholders: Increased institutional ownership may lead to greater market liquidity and potentially influence stock price due to the presence of a significant investor.
• Management: May face increased scrutiny or engagement from a large institutional holder.
• Potential Investors: The filing provides information about a substantial shareholder, which can be a factor in investment decisions.

Next Steps

• Continued monitoring of Neurogene Inc.'s business developments and any further filings by significant shareholders.

Key Dates

Keywords

Neurogene Inc., Jennison Associates LLC, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Investment Adviser